Chemomab Therapeutics Ltd.

Biotechnology • Healthcare • Tel Aviv, Israel • CMMB (NCM)

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.

972 77 331 0156 Building 7, Israel

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Yahoo Finance • Nov 20

Chemomab Therapeutics (Nasdaq: CMMB) Phase 2 PSC trial data support nebokitug Phase 3 move - Stock Titan

Stock Titan • Dec 2

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology - GlobeNewswire

GlobeNewswire • Dec 2

Chemomab Therapeutics Announces Positive Phase 2 SPRING Trial Results for Nebokitug as Promising Treatment for Primary Sclerosing Cholangitis at BSG Live’25 - Nasdaq

Nasdaq • Jun 30

Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial - TipRanks

TipRanks • Nov 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Chemomab Therapeutics Ltd. had layoffs?

No layoff events have been recorded for Chemomab Therapeutics Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Chemomab Therapeutics Ltd. in?

Chemomab Therapeutics Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is Chemomab Therapeutics Ltd. a publicly traded company?

Yes, Chemomab Therapeutics Ltd. is publicly traded under the ticker symbol CMMB on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Chemomab Therapeutics Ltd. headquartered?

Chemomab Therapeutics Ltd. is headquartered in Tel Aviv, Israel at Building 7, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.